InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	VIRALYTICS LIMITED (VLA)
Date of Listing:	15 October 1986
Date of Delisting:	21 June 2018
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 21 June 2018.

Legal Status: (updated monthly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

VIRALYTICS LIMITED(VLA)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
PSIRON LIMITED	17/08/2000	28/12/2006
MEDICAL INNOVATIONS LIMITED		17/08/2000

Shareholder links

Our website ranking of VLA:

(5 out of 5)

COMPANY WEBSITE:

VLA website

VLA contact

VLA investorRelations

VLA announcements

VLA annualreports

VLA directors

REGISTRY:

Level 21, 10 Eagle Street Brisbane QLD 4000

Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: c/- Company Matters Pty Limited Level 12, 680 George St Sydney NSW 2000
Tel: +61 2 9988 4000 Fax: +61 2 8068 6038

Date first listed: 15/10/1986
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Intellectual property and investment company operating in the health care industry. In addition to the companies it invests in, Psiron has a number of active projects at various stages of development - these include treatments for dermatological condition

News & Events

Expand this box to read and print

delisted from the close of trading on Thursday 21 June 2018 pursuant to Listing rule 17.11.	21/06/2018
we understand Merck Sharp & Dohme was successful with a cash offer of $1.75 per VLA share	21/06/2018
The scheme of arrangement between its shareholders and Merck Sharp & Dohme was approved by shareholders on 28 May 2018, and by the Federal Court of Australia on 4 June 2018 was implemented today. Viralytics is now 100% owned by MSD.	20/06/2018
The securities of Viralytics Limited will be suspended from quotation at the close of trading today, Tuesday, 5 June 2018 in accordance with Listing Rule 17.2, following lodgement with the Australian Securities and Investments Commission of the orders of the Federal Court of Australia approving the scheme of arrangement by which Merck Sharp & Dohme Pty Ltd will acquire all of the issued shares in the Company.	05/06/2018
a General Meeting is to be held at 11:00am on Thursday, 6 March 2014, at offices of McCullough Robertson, Level 15, 55 Hunter St, Sydney	04/02/2014
The suspension of trading in the securities of Viralytics Limited will be lifted immediately, following receipt of an announcement regarding a capital raising	22/11/2012
The securities of Viralytics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the outcome of a capital raising. Security Code: VLA	21/11/2012
we understand that on or about this date the company consolidated its shares 1 for 10	10/08/2011
name changed from Psiron Limited	28/12/2006

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Purchases Sales

DATE	DIRECTOR	NUMBER	PRICE	AMOUNT
01/12/2016	Paul Hopper	10,000	$1.155	$11,550.00
21/11/2016	Paul Hopper	5,000	$1.195	$5,975.00
15/11/2016	Paul Hopper	5,000	$1.275	$6,375.00
06/05/2016	Paul Hopper	6,000	$0.800	$4,800.00
02/12/2014	Peter Turvey	77,274	$0.320	$24,728.00

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Malcolm McColl	Managing Director, CEO	14/11/2012
Robert Vickery	CFO	21/05/2013
Riad El-Dada	Director	20/06/2018
Paul Dodd	Director	20/06/2018
Georgina Diab	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.